NIH-funded T32 Research Training Funds to Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital with funding slots available beginning June 1 and July 1, 2022.
The Harvard University Center for AIDS Research virtual Grand Rounds series represents an opportunity for Harvard-affiliated HIV researchers and their collaborators to learn about and share high impact, cutting-edge research to the HU CFAR community. If you’re interested in presenting at a future webinar, suggest a topic, or learn more about it, please contact Mark Ingaciola at...
Promising findings lead to initiation of a clinical efficacy trial in southern Africa
BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.
The George Washington University School of Medicine and Health Sciences (SMHS) invites applications and nominations for the position of chair of the Department of Microbiology, Immunology, & Tropical Medicine (MITM).
A position for a postdoctoral research fellow is immediately available at the Forsyth Institute in Cambridge, Massachusetts
We are very excited to embark on a NIH-sponsored project to develop a novel oral vaccine against HIV/AIDS. A postdoctoral fellow with a strong background in Immunology is sought for the careful planning and implementation of research projects involving assessments of mucosal/cellular immune responses to our novel HIV vaccine.
HIV infection increases mortality in African women with cervical cancer
“Botswana was the first country in Africa to provide comprehensive HIV treatment to its citizens and has one of the most effective antiretroviral treatment programs globally,” Scott Dryden-Peterson, MD, instructor of medicine at Harvard Medical School and associate physician at Brigham and Women’s Hospital, told HemOnc Today. “As such, trends in Botswana are indicative of what will happen in other heavily HIV affected countries that also now have good access...